La catena delle opzioni mostra i dati chiave delle opzioni azionarie di CalciMedica a vari prezzi di esercizio e date di scadenza. I trader utilizzano queste informazioni per analizzare potenziali operazioni e valutare il sentiment del mercato per CalciMedica..

CalciMedica (NASDAQ:CALC) Azioni, Catena delle Opzioni

CALCIMEDICA INC

CalciMedica

CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapeutics that treat serious illnesses driven by inflammatory and immunologic processes and direct cellular damage. Its product candidates act upon calcium release-activated calcium (CRAC) channels and would constitute a new class of drugs. Its product candidate is Auxora, a potent and selective intravenous formulated small molecule CRAC channel inhibitor containing the active compound zegocractin (formerly referred to as CM4620) that, in animal models, reduced acute epithelial and/or endothelial cell injury and inflammation in organs, such as the pancreas, lungs and kidneys.

Oracle Corporation&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ORCL#NYSE">ORCL</a>) has declared a significant reduction in&nbsp;its database software and cloud-computing&nbsp;service prices for the federal government
What Happened: Oracle is offering a 75% discount on its license-based software — including databases and analytics tools — to government agencies. Additionally, the company is offering a &#8220;substantial&#8221; discount on its cloud service until the end of November, as stated by the General Services Administration (GSA), <a href="https://www.wsj.com/articles/oracle-gives-u-s-government-discount-on-cloud-and-software-9d893fc4?reflink=desktopwebshare_permalink&amp;st=kuMQUR&amp;">detailed</a> by The Wall Street Journal.
The GSA, which handles procurement for the federal government, revealed that its agreement with Oracle is the first of its kind to provide a government-wide discount on cloud infrastructure. The agency is also in talks with other cloud providers to explore the possibility of securing similar agreements.
Oracle's agreement also includes granting the federal government access to its AI services and offering specialized support for migrating IT systems to the cloud. Traditionally recognized for its database software, the company has recently expanded its government collaborations, launching a new program last month to help smaller vendors sell technology to the Defense Department.
The GSA aims to achieve these savings by negotiating directly with tech companies and bypassing third parties. The agency anticipates securing longer-term discounts with tech providers in the near future.
SEE ALSO:&nbsp;<a href="https://benzinga.com/news/politics/25/07/46268640/china-expresses-concern-to-eu-over-russias-potential-defeat-in-ukraine-conflict-amid-fears-that-tru" target="_blank" rel="noreferrer noopener">China Expresses Concern To EU Over Russia&#8217;s Potential Defeat In Ukraine Conflict Amid Fears That Trump Would Do &#8216;This&#8217;: Report</a>
Why It Matters: Oracle&#8217;s recent move aligns with its <a href="https://www.benzinga.com/trading-ideas/movers/25/07/46248645/oracle-shares-soared-higher-over-the-past-month-whats-going-on">strong performance </a>over the past month, as the company&#8217;s shares soared by more than 30%. The company kicked off June with robust fourth-quarter earnings, surpassing estimates.
Oracle&#8217;s CEO, Safra Catz, noted a &#8220;strong start&#8221; to fiscal 2026, <a href="https://www.benzinga.com/trading-ideas/movers/25/06/46171946/oracle-stock-hits-all-time-high-after-ceo-flags-strong-start-to-fiscal-2026">with the </a>company&#8217;s MultiCloud database revenue experiencing over 100% growth. This growth trajectory, coupled with Oracle&#8217;s strategic edge in the global AI race, may have influenced the company&#8217;s decision to offer these unprecedented discounts to the U.S. government.
During its fourth quarter earnings results, Oracle&#8217;s Chairman, Larry Ellison, highlighted the company&#8217;s <a href="https://www.benzinga.com/markets/earnings/25/06/45909157/larry-ellison-says-most-of-the-worlds-valuable-data-is-in-oracle-as-ai-demand-skyrockets">competitive strength</a> in its deep integration inside enterprise data architecture, a factor that allows it to compete successfully against other giants in the AI space.
On a year-to-date basis, oracle stock surged 42.94%, as per <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.
<ul class="wp-block-list">
<li>READ MORE: <a href="https://www.benzinga.com/markets/tech/25/07/46204491/microsofts-ai-and-cloud-scale-drives-market-beating-returns">Microsoft&#8217;s AI And Cloud Scale Drives Market-Beating Returns</a> </li>
</ul>
Image via Shutterstock
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

News

ORCL

Oracle Offers Deep Discounts To US Government On AI, Cloud And Database Tools: Report

U.S. stock futures declined on Monday after scaling fresh records in the previous truncated week. Futures of major benchmark indices were trading lower.
President Donald Trump said that he would be sending out letters to America's trading partners, announcing that <a href="http://market-summary/25/07/46267527/dow-futures-slip-over-100-points-amid-trumps-august-deadline-on-tariffs">tariffs would be back</a> to April 2 levels if there was no progress being made on signing a trade deal with the U.S. by then.
Trump also signed a <a href="https://www.benzinga.com/news/politics/25/07/46263434/trump-signs-sweeping-tax-and-spending-bill-that-cbo-says-will-add-3-3-trillion-to-us-deficit-cut-health-coverage-for-11-8-million-americans">sweeping tax and spending bill</a> into law last Friday at a White House July 4 picnic, calling it a historic victory.
This move comes despite projections from the Congressional Budget Office that it will significantly expand the federal deficit and cause millions to lose their insurance coverage. Meanwhile, he also threatened an additional 10% tariff on any country that <a href="https://www.benzinga.com/news/politics/25/07/46267477/trump-threatens-10-additional-tariff-on-all-brics-aligned-nations-says-tariff-letters-drop-at-noon-monday">aligns with BRICS</a>' anti-American policies
The 10-year Treasury bond yielded 4.34% and the two-year bond was at 3.85%. 
<figure class="wp-block-table is-style-stripes"> 
<table class="has-fixed-layout">
<tbody>
<tr>
<td>Futures</td>
<td>Change (+/-)</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>-0.17%</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>-0.41%</td>
</tr>
<tr>
<td>Nasdaq 100</td>
<td>-0.55%</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>-0.53%</td>
</tr>
</tbody>
</table>
</figure>
The SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) and Invesco QQQ Trust ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>), which track the S&amp;P 500 index and Nasdaq 100 index, respectively, were lower in premarket on Monday. The SPY was down 0.39% at $622.87, while the QQQ declined 0.58% to $553.01, according to <a href="https://pro.benzinga.com/dashboard">Benzinga P</a>ro data.
Cues From Last Session:
On Thursday, the financial, information technology, and industrials sectors led the gains on the S&amp;P 500, with all sectors closing positively as U.S. stocks settled higher. The S&amp;P 500 even hit record highs following the release of jobs data.
Investor sentiment got a big boost from June's nonfarm payrolls report. It showed the U.S. economy added a robust 147,000 jobs, significantly more than the 110,000 forecast.
This encouraging data helped calm worries that arose from a weak private payroll report just the day before.
Plus, the unemployment rate dipped to 4.1% from 4.2%, also beating forecasts for a rise to 4.3%, marking its lowest point since January 2025.
Tech stocks were at the forefront of this rally, with the &#8220;Magnificent Seven&#8221; companies collectively reaching a market cap of $18.1 trillion.
Nvidia Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) solidified its position as the world's most valuable company, soaring past a $3.9 trillion valuation, ahead of Microsoft Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>) at $3.7 trillion.
In other news, Tripadvisor Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRIP#NASDAQ">TRIP</a>) shares surged around 17% after activist investor Starboard Value acquired a 9% stake in the company.
<figure class="wp-block-table is-style-stripes"> 
<table class="has-fixed-layout">
<tbody>
<tr>
<td>Index</td>
<td>Performance (+/-)</td>
<td>Value</td>
</tr>
<tr>
<td>Nasdaq Composite</td>
<td>1.02%</td>
<td>20,601.10</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>0.83%</td>
<td>6,279.35</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>0.77%</td>
<td>44,828.53</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>1.02%</td>
<td>2,249.04</td>
</tr>
</tbody>
</table>
</figure>
Insights From Analysts:
Ryan Detrick from Carson Research pointed out that the S&amp;P 500 has made 738 new all-time highs since 1990 till Thursday, suggesting that &#8220;Future returns are actually stronger than the at-any-time returns.&#8221;
He said, &#8220;Many are scared of heights, but history says you shouldn&#8217;t be.&#8221;
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Since 1990, the S&amp;P 500 has made 738 new all-time highs. Future returns are actually stronger than the at-any-time returns. Many are scared of heights, but history says you shouldn&#39;t be. <a href="https://t.co/7bQF08SugU">pic.twitter.com/7bQF08SugU</a>
&mdash; Ryan Detrick, CMT (@RyanDetrick) <a href="https://twitter.com/RyanDetrick/status/1942060247817883806?ref_src=twsrc%5Etfw">July 7, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
He also pointed out historical data where if the S&amp;P 500 index was up by 5% to 10% in the first half of the year since 1950, the index returned 6.4% on average in the next six months, and it ended with a positive return at least 86.7% of the time.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">S&amp;P 500 up between 5-10% YTD at the midpoint? Final six months higher 13 out of 15 times and full year up 14 out of 15 times. With better than average returns as well. <a href="https://t.co/IsTVtAP1r1">pic.twitter.com/IsTVtAP1r1</a>
&mdash; Ryan Detrick, CMT (@RyanDetrick) <a href="https://twitter.com/RyanDetrick/status/1941923109977698568?ref_src=twsrc%5Etfw">July 6, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Global stocks, as tracked by the iShares MSCI World ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/URTH#NYSE">URTH</a>), <a href="https://www.benzinga.com/markets/equities/25/07/46269226/stocks-just-hit-rare-golden-cross-for-1st-time-since-2023-heres-what-it-means-for-investors">formed a &#8220;Golden Cross&#8221;</a> for the first time since January 2023, according to a chart shared by Barchart. 
This bullish signal, where the 50-day moving average crosses above the 200-day moving average, also appeared on charts for the SPY and the QQQ.
Historically, the last time URTH formed a Golden Cross, returns surged by 43% over the subsequent two years.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Global Stocks just formed a Golden Cross for the first time since January 2023 &#x1f6a8; The last one sent prices soaring 43% over the next 2 years &#x1f4c8;&#x1f4c8; <a href="https://t.co/uEYq9lZZDC">pic.twitter.com/uEYq9lZZDC</a>
&mdash; Barchart (@Barchart) <a href="https://twitter.com/Barchart/status/1935138827716411718?ref_src=twsrc%5Etfw">June 18, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Looking back to 1975, a &#8220;golden cross&#8221; on the S&amp;P 500 chart has historically been a strong positive sign, leading to higher returns 88% of the time over the next year. According to Subu Trade, the S&amp;P 500&#8217;s average return after such an event over the past 50 years has been an impressive 12.29%.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">The S&amp;P 500 has formed a &quot;Golden Cross&quot; (50 day moving average crossed above 200 day moving average). Here&#39;s every Golden Cross in the past 50 years, and what the S&amp;P did next: <a href="https://t.co/ARrLMwmsWp">pic.twitter.com/ARrLMwmsWp</a>
&mdash; Subu Trade (@SubuTrade) <a href="https://twitter.com/SubuTrade/status/1940071700609335571?ref_src=twsrc%5Etfw">July 1, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
See Also: <a href="https://www.benzinga.com/money/how-to-trade-futures">How to Trade Futures </a>
Upcoming Economic Data
Here&#8217;s what investors will keep an eye on this week:
<ul class="wp-block-list">
<li>No data is scheduled to be released on Monday.</li>
<li>June&#8217;s NFIB optimism index data will be out by 6:00 a.m. ET.</li>
<li>May&#8217;s consumer credit data will be released by 3:00 p.m. ET.</li>
<li>On Wednesday, the wholesale inventories data will be out by 10:00 a.m. ET.</li>
<li>Minutes of the Fed&#8217;s May FOMC meeting will be released by 2:00 p.m. ET.</li>
<li>On Thursday, initial jobless claims data for the week ended July 5 will all be out by 8:30 a.m. ET.</li>
<li>St Louis Fed President Alberto Musalem will speak at 10:00 a.m., and San Francisco Fed President Mary Daly will speak at 2:30 p.m. ET.</li>
<li>On Friday, monthly U.S. federal budget data will be released at 2:00 p.m. ET.</li>
</ul>
Stocks In Focus:
<ul class="wp-block-list">
<li>Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) dropped 6.55% as Elon Musk announced the launch of a new political party following the Senate&#8217;s approval of the Big Beautiful Bill. The new tax bill has axed the $7500 EV credit as well as made ZEV or Zero Emission vehicle credits.</li>
<li>Taiwan Semiconductor Manufacturing Co. Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TSM#NYSE">TSM</a>) was 1.68% lower as it announced delaying its second Japanese chips plant while increasing investment in U.S. expansion, influenced by potential Trump tariffs.</li>
<li>WNS (Holdings) Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WNS#NYSE">WNS</a>) jumped 12.42% after being acquired by Capgemini for agentic AI-powered operations.</li>
<li>Sharps Technology Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STSS#NASDAQ">STSS</a>) fell by 0.86% in premarket on Monday, as it named Paul Danner as Executive Chairman last week.</li>
<li>Quantum-Si Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QSI#NASDAQ">QSI</a>) declined 11.21% after announcing the pricing of $50 million registered direct offering of common stock.</li>
<li>Boeing Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BA#NYSE">BA</a>) was 0.42% lower after securing a $2.8 billion contract from the U.S. Space Force to develop and produce strategic satellite communications systems.</li>
<li>Sonnet BioTherapeutics Holdings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SONN#NASDAQ">SONN</a>) surged 61.22% premarket after announcing a $2.0 million private placement of zero-interest convertible notes and accompanying warrants.</li>
<li>Northern Dynasty Minerals Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NAK#NYSE">NAK</a>) climbed 18.57% after announcing that ongoing negotiations with the Environmental Protection Agency (EPA) regarding a potential settlement in the Pebble Mine case.</li>
</ul>
Commodities, Gold, And Global Equity Markets:
Crude oil futures were trading higher in the early New York session by 0.53% to hover around $66.85 per barrel.
Gold Spot US Dollar fell 0.83% to hover around $3,309.32 per ounce. Its last record high stood at $3,500.33 per ounce. The U.S. Dollar Index spot was higher by 0.23% at the 97.4000 level.
Asian markets ended lower on Monday except the South Korea's Kospi index, as India's S&amp;P BSE Sensex, Hong Kong's Hang Seng, and Australia's ASX 200, Japan's Nikkei 225, and China&#8217;s CSI 300 indices fell. European markets were mixed in early trade.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/equities/25/07/46269226/stocks-just-hit-rare-golden-cross-for-1st-time-since-2023-heres-what-it-means-for-investors">Stocks Just Hit Rare Golden Cross For 1st Time Since 2023 — Here&#8217;s What It Means For Investors</a></li>
</ul>
Photo courtesy: godongphoto / Shutterstock.com

Equities

MSFT

NVDA

SONN

STSS

TRIP

TSLA

URTH

US Stocks Likely To Open Lower After A Week Of Records: Tesla In Focus As Elon Musk Announces America Party

Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) CEO Elon Musk has reignited the debate surrounding the Jeffrey Epstein row amid rising tensions with U.S. President Donald Trump.
What Happened: Musk took to social media platform X on Monday to express his discontentment with the lack of arrests in the Jeffrey Epstein case.
"What's the time? Oh look, it's no-one-has-been-arrested-o'clock again," he said in the post, which had an image of a counter or a digital clock with the numbers ‘0000' on it.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">What's the time? Oh look, it's no-one-has-been-arrested-o'clock again … <a href="https://t.co/CO9xJz68Tf">pic.twitter.com/CO9xJz68Tf</a>
&mdash; Elon Musk (@elonmusk) <a href="https://twitter.com/elonmusk/status/1942132189229162960?ref_src=twsrc%5Etfw">July 7, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Musk's post could be another attack by the billionaire on President Trump and the administration over what Musk believes is a lack of legal action on the government's part over the case.
Why It Matters: The comments echo Musk's previous statement as tensions first rose between him and Trump. The billionaire made a post on X, alleging that the reason why there were no arrests made was because <a href="https://www.benzinga.com/news/politics/25/06/45828121/elon-musks-bombshell-about-donald-trump-in-epstein-docs-heres-the-truth-behind-the-claim">Trump was on the Epstein list</a>. Musk, however, did not provide any evidence to support the claim.
It's worth noting that he later retracted the statement and deleted the post from X and the pair had<a href="https://www.benzinga.com/news/politics/25/06/45807968/trump-signals-truce-with-elon-musk-after-online-feud-its-going-very-well-never-done-better"> reached a truce</a>. However, the billionaire recently vowed to <a href="https://www.benzinga.com/news/politics/25/06/46186733/elon-musk-staging-a-political-comeback-tesla-ceo-sparks-america-party-buzz-as-he-slams-trumps-insane-spending-bill">found a political party</a> as the Big, Beautiful Bill was passed by the Senate and signed into law on the Fourth of July.
While Musk says that the tax cuts would add trillions to the U.S. debt deficit, it's worth noting that the Bill axes the $7,500 EV credit on all new electric vehicles, which could have a significant impact on Tesla's <a href="https://www.benzinga.com/markets/tech/25/07/46189042/elon-musk-led-teslas-european-woes-worsen-with-sales-down-over-60-in-sweden-and-denmark">already dwindling sales</a>.&nbsp;
Trump had, in turn, said that Musk's companies were on the receiving end of many government subsidies and that without them, the billionaire would have to <a href="https://www.benzinga.com/news/politics/25/07/46216023/after-trump-warns-elon-musk-to-close-up-shop-china-rallies-behind-worlds-richest-man-theres-no-need-to-keep-putting-up-with-it">"close up shop"</a> and move back to South Africa. 
However, Musk's decision to found the America Party has invited <a href="https://www.benzinga.com/news/politics/25/07/46266957/trump-calls-america-party-a-train-wreck-blasts-elon-musk-for-going-completely-off-the-rails-president-says-system-not-designed-for-a-third-player">criticism from both Trump</a>, who called the move a "train wreck," as well as former DOGE advisor James Fishback, who believes Musk's commitment to Tesla <a href="https://www.benzinga.com/markets/tech/25/07/46268694/elon-musks-america-party-plans-conflict-with-his-full-time-responsibilities-as-tesla-ceo-says-former-doge-advisor">could be under question</a>.
Tesla offers satisfactory Momentum while scoring well on the Growth and Quality metrics, but the stock offers poor Value. For more such insights, sign up for<a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound"> Benzinga Edge Stock Rankings</a> today!
Check out more of Benzinga&#8217;s Future Of Mobility coverage by<a href="https://www.benzinga.com/topic/mobility"> following this link.</a>
Read Next
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/tech/25/07/46270052/as-trumps-big-beautiful-bill-is-signed-into-law-these-evs-from-tesla-gm-and-ford-will-become-more-expensive">As Trump&#8217;s &#8216;Big, Beautiful Bill&#8217; Is Signed Into Law, These EVs From Tesla, GM And Ford Will Become More Expensive: Report</a></li>
</ul>
Photo courtesy: Shutterstock

Politics

General

Elon Musk Reignites Epstein Client List Debate, Escalating Feud With Trump

Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) stock plummeted nearly 7% in Monday pre-market trading in response to CEO Elon Musk&#8217;s re-entry into the political landscape amid his ongoing dispute with President Donald Trump over the contentious &#8220;Big, Beautiful Bill.&#8221;
What Happened: The decline follows Musk&#8217;s announcement of the formation of a new political party, in response to the Senate&#8217;s approval of the &#8220;Big, Beautiful Bill.&#8221; This bill has eliminated the $7500 EV credit and rendered the Zero Emission Vehicle (ZEV) credits, a significant revenue source for Tesla, effectively obsolete.
Over the weekend, Musk announced that the party would be named the "America Party" and might concentrate on "just 2 or 3 Senate seats and 8 to 10 House districts." He argued that this would be sufficient to hold the deciding vote on divisive legislation, helping ensure such laws reflect the true will of the people.
However, Elon Musk denied filing for the registration of the political party the Federal Election Commission. 
Trump criticized Musk&#8217;s move as &#8220;a train wreck&#8221; on Truth Social, questioning the necessity for a third political party in the U.S.
SEE ALSO: <a href="https://benzinga.com/personal-finance/entrepreneurship/25/07/46266500/mark-cuban-says-his-children-struggle-with-the-downsides-of-his-wealth-not-that" target="_blank" rel="noreferrer noopener">Mark Cuban Says His Children Struggle With the Downsides of His Wealth: &#8216;Not That They Want To Be Poor, But It Sets An Expectation&#8217;</a>
Why It Matters: This development comes on the heels of Musk&#8217;s decision to establish a political party, which has raised concerns among investors. Former DOGE advisor and Tesla investor, James Fishback, expressed that this move <a href="https://www.benzinga.com/markets/tech/25/07/46268694/elon-musks-america-party-plans-conflict-with-his-full-time-responsibilities-as-tesla-ceo-says-former-doge-advisor">undermines </a>investor confidence in the EV giant. His investment company Azoria Partners also postponed the launch of Tesla Convexity ETF on this note.
Musk stepped away from DOGE in May, a move that benefited Tesla's stock. However, his renewed involvement in politics is now unsettling investors.
The formation of the "America Party" by Musk has elicited <a href="http://The formation of the "America Party" by Musk has elicited mixed reactions among investors, analysts, and loyalists. While some see it as a step in the wrong direction, others believe it's too early to predict the impact on Tesla's brand in the short term">mixed reactions</a> among investors, analysts, and loyalists. While some see it as a step in the wrong direction, others believe it&#8217;s too early to predict the impact on Tesla&#8217;s brand in the short term.
"Very simply Musk diving deeper into politics and now trying to take on the Beltway establishment is exactly the opposite direction that Tesla investors/shareholders want him to take during this crucial period for the Tesla story," stated Dan Ives, the lead technology analyst at Wedbush. 
<ul class="wp-block-list">
<li>READ MORE: <a href="https://www.benzinga.com/markets/tech/25/07/46268433/teslas-full-self-driving-tech-under-fire-again-after-robotaxi-nearly-hits-parked-vehicle-report">Tesla&#8217;s Full Self-Driving Tech Under Fire Again After Robotaxi Nearly Hits Parked Vehicle: Report </a></li>
</ul>
Image via Shutterstock
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Tesla Stock Falls Over 6% In Monday Pre-Market: What's Going On?

Indosat Ooredoo Hutchison, a leading Indonesian <a target="_blank" href="https://www.benzinga.com/topic/telecommunications" rel="noreferrer noopener">digital telecom provider</a>, has adopted Nokia Corp.&#8217;s (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOK#NYSE">NOK</a>) Energy Efficiency solution from its Autonomous Networks portfolio to cut energy use and lower CO₂ emissions across its national radio access network (RAN).
Leveraging AI and machine learning to analyze real-time traffic, the solution allows Indosat to automatically power down idle or underutilized radio equipment during <a target="_blank" href="https://www.nokia.com/newsroom/indosat-ooredoo-hutchison-and-nokia-partner-to-reduce-energy-demand-and-support-ai-powered-sustainable-operations/" rel="noreferrer noopener">low-demand periods</a>.
Intelligent thermal management also reduces cooling-related energy consumption.
Also Read: <a target="_blank" href="https://www.benzinga.com/markets/tech/25/06/45855187/nokia-taps-amd-processors-to-power-next-gen-5g-networks" rel="noreferrer noopener">Nokia Taps AMD Processors To Power Next-Gen 5G Networks</a>
Delivered via a SaaS model, the solution avoids enormous upfront costs and removes the need for on-site maintenance, making it a greener and more efficient alternative, the company said in a press release.
The multi-vendor, AI-powered platform helps reduce both energy costs and environmental impact without compromising network performance or customer service.
The deployment follows a successful pilot in which Nokia&#8217;s solution effectively cut live network energy use. Nokia has expanded the rollout across its entire RAN footprint in Sumatra, Kalimantan, Central, and East Java.
Nokia stock surged over 16% year-to-date, topping the NYSE Composite&#8217;s close of 9%, backed by licensing deals and positive performance in its Network Infrastructure, Cloud, and Network Services divisions. The acquisition of&nbsp;Infinera&nbsp;and strategic partnerships also added to investor confidence.&nbsp;The stock gained over 33% in the last 12 months versus the index&#8217;s close to 15%.
Ten analysts have set an <a target="_blank" href="https://www.benzinga.com/quote/NOK/analyst-ratings" rel="noreferrer noopener">average price target</a> of $5.44 for Nokia. Craig-Hallum gave the highest target of $7 on January 6, 2025. The three most recent ratings assigned an average target of $6.55, suggesting a potential upside of 27.18% from Nokia&#8217;s current price.
Price Action: NOK stock is trading lower by 0.77% to $5.15 premarket at last check Monday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/tech/25/07/46226585/microsoft-cuts-9000-jobs-in-second-2025-layoff" target="_blank" rel="noreferrer noopener">Microsoft Cuts 9,000 Jobs In Second 2025 Layoff As AI Expansion Pushes Cost Controls</a></li>
</ul>
Photo via Shutterstock

Tech

Nokia's AI Tech Powers Greener Mobile Networks In Indonesia

<a href="https://www.globenewswire.com/Tracker?data=jOj9DfnKSuYl1Xwk06kWA8ewX02OI0s91dVuEtif4azitvqRSzsEDIYGETaQBTqmqNsHTgS9XEMElT2_QQbDysZndQBcmIx0a9zVv9gyYMU=">Hyperscale Data, Inc.</a>&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GPUS#NYSE">GPUS</a>), a diversified holding company ("Hyperscale Data" or the "Company"), today announced that its indirect, wholly owned subsidiary, Ault Markets, Inc. ("Ault Markets"), plans to launch a validator node on the Solana blockchain. This initiative marks a further step in Hyperscale Data's strategy to deepen its engagement with decentralized technologies and enhance its blockchain infrastructure services.
Ault Markets' entry into Solana validation is a milestone in Hyperscale Data's broader vision to integrate real-time blockchain operations across its portfolio of artificial intelligence ("AI"), digital assets and financial technology platforms. Ault Markets' plan involves:
<ul>
<li>Validator Launch on Solana – Ault Markets plans to deploy a high-performance validator node on the Solana blockchain in the third quarter of 2025, enabling participation in transaction validation and block production.</li>
<li>Delegation and Reward Model – The validator will support delegated staking, offering rewards to internal operations and external participants through a fair and transparent distribution structure.</li>
<li>Infrastructure-Driven Vision – The validator launch aligns with Hyperscale Data's long-term objective to build secure, high-throughput infrastructure to support next-generation blockchain and AI workloads.</li>
<li>Protocol-Level Engagement – Ault Markets is preparing an application for the Solana Foundation Delegation Program, aiming to become a key infrastructure partner within the Solana ecosystem.</li>
</ul>

GPUS

Hyperscale Data Enters Solana Blockchain With Validator Launch, Expands Crypto and AI Footprint

Molina Healthcare, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MOH#NYSE">MOH</a>) today announced preliminary financial results for the second quarter of 2025 and updated its full year 2025 adjusted earnings per share guidance. The Company's announcement of preliminary results was driven by recent market dynamics and off-cycle disclosures from others in the managed health care sector.
The Company now expects its second quarter 2025 adjusted earnings to be approximately $5.50 per share(1), which is modestly below its prior expectations. This preliminary result reflects medical cost pressures in all three lines of business. The Company expects these medical cost pressures to continue into the second half of the year. As a result, the Company now expects its full year 2025 adjusted earnings to be in the range of $21.50 to $22.50 per share(1), reflecting a consolidated pre-tax margin of just under 4%, the low-end of its long-term guidance range.

Guidance

Molina Sees Q2 EPS at $5.50 Vs $6.21 Est, Cuts Full-Year EPS Outlook to $21.50–$22.50 (Prior $24.50) Amid Rising Medical Costs

<a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.kalvista.com%2F&amp;esheet=54285411&amp;newsitemid=20250702871458&amp;lan=en-US&amp;anchor=KalVista+Pharmaceuticals&amp;index=1&amp;md5=7045bfbd1824b7fd85288706aa011120">KalVista Pharmaceuticals</a>, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KALV#NASDAQ">KALV</a>) today announced that the U.S. Food and Drug Administration (FDA) has approved EKTERLY&#xAE; (sebetralstat), a novel plasma kallikrein inhibitor, for the treatment of acute attacks of hereditary angioedema (HAE) in adult and pediatric patients aged 12 years and older. EKTERLY is the first and only oral on-demand treatment for HAE.

Government

Regulations

KALV

KalVista Wins FDA Nod for EKTERLY, A New Pill to Treat Sudden HAE Attacks

Shares of Apogee Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APGE#NASDAQ">APGE</a>) rose sharply in today's pre-market trading after the company disclosed positive 16-week data from Phase 2 APEX clinical trial of APG777, its potentially best-in-class anti-IL-13 antibody, in moderate-to-severe atopic <a href="https://www.benzinga.com/quote/APOG">dermatitis</a>.
Apogee Therapeutics shares jumped 50% to $71.19 in the pre-market trading session.
Here are some other stocks moving in pre-market trading.
<h3 class="wp-block-heading">Gainers</h3>
<ul class="wp-block-list">
<li>Mullen Automotive, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MULN#NASDAQ">MULN</a>) surged 80.2% to $0.4030 in pre-market trading. Mullen Automotive recently announced it is now accepting Bitcoin and TRUMP Coin for EV purchases.</li>
<li>Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SONN#NASDAQ">SONN</a>) gained 52.2% to $5.97 in pre-market trading after falling more than 5% on Thursday.</li>
<li>MediaCo Holding Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MDIA#NASDAQ">MDIA</a>) rose 32.7% to $1.46 in pre-market trading after falling 3% on Thursday.</li>
<li>Inno Holdings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INHD#NASDAQ">INHD</a>) climbed 28% to $1.51 in pre-market trading after dipping 19% on Thursday.</li>
<li>Northern Dynasty Minerals Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NAK#NYSE">NAK</a>) jumped 23.9% to $1.74 in pre-market trading.</li>
<li>K Wave Media Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KWM#NASDAQ">KWM</a>) gained 17.6% to $5.06 in pre-market trading after gaining 13% on Thursday.</li>
<li>Regencell Bioscience Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RGC#NASDAQ">RGC</a>) gained 14% to $26.20 in pre-market trading after jumping 122% on Thursday.</li>
<li>WNS (Holdings) Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WNS#NYSE">WNS</a>) gained 12.9% to $73.90 in pre-market trading after Capgemini SE (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CGEMY#OTC">CGEMY</a>) announced that it will acquire WNS Holdings in a $3.3 billion all-cash deal to create a global leader in Agentic AI-powered Intelligent Operations.</li>
<li>So-Young International Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SY#NASDAQ">SY</a>) gained 10.8% to $3.60.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul class="wp-block-list">
<li>Bitmine Immersion Technologies, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BMNR#NYSE">BMNR</a>) shares tumbled 19.3% to $110.00 in pre-market trading. BitMine Immersion Technologies shares jumped over 130% on Thursday after the company on Monday announced a $250 million private placement to launch an Ethereum treasury strategy..</li>
<li>Enigmatig Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EGG#NYSE">EGG</a>) fell 17% to $4.72 in pre-market trading after gaining around 54% on Thursday.</li>
<li>Lixte Biotechnology Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LIXT#NASDAQ">LIXT</a>) dipped 15.2% to $2.40 in pre-market trading after gaining 40% on Thursday.</li>
<li>MingZhu Logistics Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/YGMZ#NASDAQ">YGMZ</a>) declined 14.7% to $0.87 in pre-market trading. MingZhu Logistics entered into share purchase agreement to acquire Mingzhuchun.</li>
<li>Powell Max Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PMAX#NASDAQ">PMAX</a>) dipped 13.2% to $0.4450 in pre-market trading after gaining 4% on Thursday.</li>
<li>Quantum-Si incorporated (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QSI#NASDAQ">QSI</a>) fell 10.3% to $1.92 in pre-market trading after the company announced the pricing of $50 million registered direct offering of common stock.</li>
<li>XORTX Therapeutics Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XRTX#NASDAQ">XRTX</a>) fell 10.1% to $0.8097 in pre-market trading following a 10% decline on Thursday.</li>
<li>Webull Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BULL#NASDAQ">BULL</a>) declined 9.5% to $12.95 in pre-market trading.</li>
<li>XTL Biopharmaceuticals Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XTLB#NASDAQ">XTLB</a>) shares fell 8.3% to $1.21 in pre-market trading after gaining 10% on Thursday.</li>
<li>Tesla, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) fell 6.4% to $295.32 in pre-market trading amid the billionaire&#8217;s feud with President Donald Trump, which began over the latter&#8217;s "Big, Beautiful Bill."</li>
</ul>
Now Read This: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/analyst-stock-ratings/analyst-color/25/07/46243448/cramer-doesnt-recommend-titan-international-joby-aviation-soars-after-milestone-flight">Cramer Doesn&#8217;t Recommend Titan International, Joby Aviation Soars After Milestone Flight</a> </li>
</ul>
Photo via Shutterstock

Pre-Market Outlook

Markets

Movers

Trading Ideas

APGE

APOG

BMNR

BULL

CGEMY

INHD

LIXT

MDIA

MULN

PMAX

XRTX

XTLB

YGMZ

Why Apogee Therapeutics Shares Are Trading Higher By 50%; Here Are 20 Stocks Moving Premarket

CYCC

Cyclacel Highlights Study Showing Plogosertib Targets DNAJ-PKAc Fusion In Rare Liver Cancer Fibrolamellar Hepatocellular Carcinoma

Capgemini SE (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CGEMY#OTC">CGEMY</a>) announced Monday that it will acquire WNS Holdings Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WNS#NYSE">WNS</a>) in a <a target="_blank" href="https://www.benzinga.com/pressreleases/25/07/g46267656/capgemini-to-acquire-wns-to-create-a-global-leader-in-agentic-ai-powered-intelligent-operations" rel="noreferrer noopener">$3.3 billion all-cash deal</a> to create a global leader in Agentic AI-powered Intelligent Operations.
The transaction, which offers $76.50 per WNS share, reflects a 17% premium over WNS&#8217; most recent closing price and has received unanimous approval from both companies&#8217; boards. Capgemini expects the deal to close by year-end, pending shareholder and court approvals.
The acquisition gives Capgemini access to WNS&#8217;s high-margin digital business process services and strengthens its position in the U.S. market. The combination is designed to capitalize on a growing enterprise shift toward AI-driven operational models.
Also Read: <a href="https://www.benzinga.com/markets/tech/25/07/46192736/ibm-just-tackled-one-of-techs-most-annoying-bottlenecks" target="_blank" rel="noreferrer noopener">IBM Just Tackled One Of Tech&#8217;s Most Annoying Bottlenecks</a>
Aiman Ezzat, CEO of Capgemini, said the combination is designed to capture the surge in enterprise demand for Agentic AI, which is transforming how companies manage operations from end to end. He described the merger as a step toward building a new benchmark for Intelligent Operations that leverages automation, data, and domain expertise to deliver superior results at scale.
Keshav R. Murugesh, CEO of WNS, echoed the enthusiasm, calling the deal a strategic leap toward embedding AI at the core of business models. He noted that the combined portfolio would expand Capgemini&#8217;s footprint across industries and enhance its ability to support organizations as they shift from automation to autonomy in operational strategy.
WNS <a target="_blank" href="https://www.benzinga.com/pressreleases/25/04/b44973624/wns-announces-fiscal-2025-fourth-quarter-and-full-year-earnings-provides-guidance-for-fiscal-2026" rel="noreferrer noopener">reported</a> $1.27 billion in revenue for fiscal 2025 and holds long-term contracts with companies like United Airlines and Aviva.
Capgemini expects the deal to increase normalized EPS by 4% in 2026 and 7% by 2027, post-synergies. Estimated annual revenue synergies range between 100 million euros (~$108 million) and 140 million euros (~$151.2 million), with cost savings projected up to 70 million euros (~$75.6 million).
Capgemini is funding the transaction with a 4 billion euros bridge loan, partially backed by internal cash and future debt issuance. The company plans to integrate WNS into its Global Business Services unit, citing a strong cultural fit and complementary capabilities across AI, platforms, and consulting.
Related ETFs: Global X Artificial Intelligence &amp; Technology ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AIQ#NASDAQ">AIQ</a>), iShares Expanded Tech-Software Sector ETF (BATS:<a class="ticker" href="https://www.benzinga.com/stock/IGV#BATS">IGV</a>).
Price Action: WNS shares were trading higher by 12.44% to $73.51 premarket at last check Monday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/tech/25/07/46268037/after-microsoft-lays-off-9100-workers-xbox-executive-tells-fired-workers-to-turn-to-ai-for-mental-health-help">After Microsoft Lays Off 9,100 Workers, Xbox Executive Tells Fired Workers To Turn To AI For Mental Health Help</a></li>
</ul>
Photo via Shutterstock

Capgemini Doubles Down On Agentic AI With $3.3 Billion WNS Acquisition

<a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4462893-1&amp;h=1300208705&amp;u=https%3A%2F%2Fcorporate.dow.com%2Fen-us%2F&amp;a=Dow">Dow</a>&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DOW#NYSE">DOW</a>) announced today that, as a follow-up to the European asset actions first announced in April 2025, its Board of Directors has approved the shutdown of three upstream assets in Europe, in addition to certain corporate and other assets across the Company's global asset footprint:
&nbsp;
<ul>
<li>Packaging &amp; Specialty Plastics: Ethylene cracker in Böhlen, Germany; shutdown expected in 4Q27</li>
<li>Industrial Intermediates &amp; Infrastructure: Chlor-alkali &amp; vinyl (CAV) assets in Schkopau, Germany; shutdown expected in 4Q27</li>
<li>Performance Materials &amp; Coatings: Basics siloxanes plant in Barry, U.K.; shutdown expected mid-year 2026</li>
</ul>
The shutdown of upstream assets in Europe will right-size regional capacity, reduce merchant sale exposure, and remove higher-cost, energy-intensive portions of Dow's portfolio in the region. This will improve our ability to supply profitable derivative demand and optimize margins.
"Our industry in Europe continues to face difficult market dynamics, as well as an ongoing challenging cost and demand landscape," said <a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4462893-1&amp;h=1264473883&amp;u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D4365669-1%26h%3D928999966%26u%3Dhttps%253A%252F%252Fcorporate.dow.com%252Fen-us%252Fabout%252Fcompany%252Fleadership%252Fjim-fitterling.html%26a%3DJim%2BFitterling%23xd_co_f%3DNWU5MTc3MGItMzc0Ni00OGE5LTk4YzAtOTk2NGNjMmJhYjNl%7E&amp;a=Jim%C2%A0Fitterling">Jim&nbsp;Fitterling</a>, Dow chair and CEO. "Over the past decade, we have demonstrated Dow's commitment to operating with a best-owner mindset by taking proactive actions across higher-cost or non-strategic assets. Looking ahead, we remain committed to realizing the value of our incremental growth investments and enhancing profitability and cash flow through more than $6&nbsp;billion in near-term cash support."
In April 2025, the Company <a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4462893-1&amp;h=1608642756&amp;u=https%3A%2F%2Fs23.q4cdn.com%2F981382065%2Ffiles%2Fdoc_financials%2F2025%2Fq1%2FDow-1Q25-Earnings-News-Release.pdf&amp;a=announced">announced</a>&nbsp;it had identified three assets in Europe for action across all of its operating segments. On June 30, 2025, Dow's Board of Directors approved restructuring actions to rationalize the Company's global asset footprint, including these three assets as part of its European review, and certain corporate and other assets.
Dow's actions to shut down these assets will result in an Operating EBITDA uplift beginning in 2026, ramping to 50% of the approximate $200&nbsp;million target by year-end 2027 with full delivery by 2029, with a cash outlay of approximately $500&nbsp;million over four years.
As a result of these actions, the Company will record charges ranging from $630&nbsp;million to $790&nbsp;million, for both non-cash items—such as asset write-downs and write-offs—and cash items, such as exit and disposal of assets, as well as severance and related benefit costs.
The shutdown of the assets is expected to begin in mid-2026 and is estimated to be complete by the end of 2027, with potential decommissioning and demolition to continue into 2029 as needed.
Approximately 800 Dow roles will be impacted as a result of these actions. These roles are in addition to the $1&nbsp;billion cost savings actions <a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4462893-1&amp;h=4038991573&amp;u=https%3A%2F%2Fcorporate.dow.com%2Fen-us%2Fnews%2Fpress-releases%2Fdow-announces-targeted-actions-to-deliver--1b-in-cost-savings.html&amp;a=announced+in+January">announced in January</a>&nbsp;that included a workforce reduction of approximately 1,500 Dow roles globally.

Dow to Shut European Plants, Will Take Up to $790M Hit as It Eyes $200M Profit Boost by 2029, To Impact 800 Jobs

Wabtec To Acquire Frauscher In €675M Deal To Strengthen Digital Intelligence And Rail Signaling Portfolio

As President Donald Trump's Big Beautiful Bill is officially signed into law, the bill scraps the $7,500 Federal EV credit on all purchases of new electric vehicles in the U.S.
What Happened: As the incentives are axed, EVs across the board are set to become dearer after September 30, 2025, when the incentives end. On Saturday, Business Insider compiled <a href="https://www.businessinsider.com/all-the-evs-set-to-lose-the-federal-tax-credit-2025-7">a</a> list of vehicles set for a price hike from automakers like General Motors Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GM#NYSE">GM</a>), Stellantis (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STLA#NYSE">STLA</a>), Ford Motor Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/F#NYSE">F</a>) and Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>).
As for the list of vehicles from GM, it includes EVs from GM like the Chevrolet Blazer, Equinox and Silverado, as well as luxury-focused EVs like the Cadillac Lyriq, Optiq and Vistiq.
Detroit-based automaker Ford's F-150 Lightning pickup truck will get costlier. 
Elon Musk's Tesla vehicles, like Model Y, Model X, the Cybertruck and the Model 3, are also going to cost more.
Why It Matters: The news comes as the new laws axe the federal EV credit, but also scrap the proposed $250 fee annual fee on all EVs. The law is another push in Trump's anti-EV stance.
The bill has caused a considerable stir, with Musk locking horns with Trump over the bill once again and vowing to <a href="https://www.benzinga.com/news/politics/25/07/46267705/elon-musk-says-america-first-filing-false-and-has-been-reported-to-the-election-commission">found a new political party</a> called the America Party.
However, Musk's decision has been met with criticism both from Trump, who called the idea <a href="https://www.benzinga.com/news/politics/25/07/46266957/trump-calls-america-party-a-train-wreck-blasts-elon-musk-for-going-completely-off-the-rails-president-says-system-not-designed-for-a-third-player">a "train wreck"</a> as well as experts, who suggest the move could be <a href="https://www.benzinga.com/markets/tech/25/07/46268694/elon-musks-america-party-plans-conflict-with-his-full-time-responsibilities-as-tesla-ceo-says-former-doge-advisor">detrimental to Tesla</a>.
Interestingly, Tesla stock <a href="https://www.benzinga.com/markets/tech/25/07/46267743/tesla-shares-fall-over-5-in-overnight-trading-as-elon-musk-jumps-back-into-politics">has fallen over 5%</a> in overnight trading following Musk's announcements regarding the party and his increasing involvement in politics.
<figure class="wp-block-image size-large"><a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound"><img loading="lazy" decoding="async" width="1024" height="199" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/07054250/TSLA-JUL-7-2025-2-1-1024x199.jpg" alt="" class="wp-image-974436" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/07054250/TSLA-JUL-7-2025-2-1-1024x199.jpg 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/07054250/TSLA-JUL-7-2025-2-1-300x58.jpg 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/07054250/TSLA-JUL-7-2025-2-1-768x149.jpg 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/07054250/TSLA-JUL-7-2025-2-1-1536x299.jpg 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/07054250/TSLA-JUL-7-2025-2-1.jpg 1569w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
Tesla offers satisfactory Momentum while scoring well on the Growth and Quality metrics, but the stock offers poor Value. For more such insights, sign up for <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound">Benzinga Edge Stock Rankings</a> today!
Check out more of Benzinga's Future Of Mobility coverage by<a href="https://www.benzinga.com/topic/mobility"> following this link.</a>
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/tech/25/07/46268433/teslas-full-self-driving-tech-under-fire-again-after-robotaxi-nearly-hits-parked-vehicle-report">Tesla&#8217;s Full Self-Driving Tech Under Fire Again After Robotaxi Nearly Hits Parked Vehicle: Report</a></li>
</ul>
Photo courtesy: Shutterstock

STLA

As Trump's 'Big, Beautiful Bill' Is Signed Into Law, These EVs From Tesla, GM And Ford Will Become More Expensive: Report

Apogee Therapeutics, Inc., (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APGE#NASDAQ">APGE</a>), a clinical-stage biotechnology company advancing optimized, novel biologics with potential for differentiated efficacy and dosing in the largest inflammatory and immunology (I&amp;I) markets, today announced positive 16-week data from Part A of the Phase 2 APEX clinical trial of APG777, a potential best-in-class anti-IL-13 antibody, in patients with moderate-to-severe atopic dermatitis (AD).
"With two out of every three patients treated with APG777 achieving EASI-75 response at Week 16 in the Phase 2 APEX Part A trial, APG777 demonstrated the highest EASI-75 response rate both on a topline and placebo-adjusted basis for any biologic in a global study to date, reinforcing its potential best-in-class profile for patients with moderate-to-severe atopic dermatitis," said Michael Henderson, M.D., Chief Executive Officer of Apogee. "APG777 has the potential to set a new standard of care by offering improved clinical responses with transformational quarterly or better maintenance dosing — benefitting patients, providers, and payers. Today's results bring us closer to that vision, and we believe further de-risks APG777's path to approval. In addition, I am excited for our two upcoming readouts to potentially even further improve on efficacy results — the accelerated APEX Part B testing higher exposures that is now expected to readout mid-2026, and the ongoing APG279 (IL-13 + OX40L) head-to-head trial against DUPIXENT expected to readout in the second half of 2026."
"Today's results from APEX Part A demonstrate strong efficacy results across all key endpoints," said Carl Dambkowski, M.D., Chief Medical Officer of Apogee. "In addition to these potentially best-in-class results, increased response rates were observed in patients with higher exposures, supporting our exposure-response hypothesis which we continue to further test in APEX Part B. Combined with a favorable safety profile, these findings reinforce APG777's potential to deliver meaningful and durable benefit to patients while significantly reducing dosing frequency compared with existing agents. On behalf of the entire Apogee team, I'd like to extend our gratitude to the patients and physicians for their support in the successful execution of this important trial."&nbsp;
APEX Phase 2 Part A Key 16-Week Results
The Phase 2 APEX clinical trial is a randomized, placebo-controlled study evaluating APG777 in patients with moderate-to-severe AD. Part A of the trial enrolled 123 adult patients who were randomized 2:1 to APG777 versus placebo and received an induction regimen dosing of 720mg at Weeks 0 and 2, followed by 360mg at Weeks 4 and 12. Patients benefiting from treatment continued maintenance dosing, evaluating 3- or 6-month dosing of APG777. The primary endpoint of Part A is mean percentage change in Eczema Area Severity Index (EASI) score from baseline at Week 16. Secondary endpoints include EASI-75, EASI-90, Validated Investigator Global Assessment (IGA) 0/1 and Itch Numeric Rating Scale (NRS) at Week 16.
Initial 16-week findings from APEX Part A include efficacy results, which compare favorably versus standard of care across endpoints as well as rapid onset of itch relief and lesion reduction, and a favorable safety profile consistent with its class:
<ul>
<li>The trial met its primary endpoint, with APG777 showing significantly greater least squares mean percent change from baseline at Week 16 with an EASI reduction of 71.0% compared to placebo of 33.8% (p &lt; 0.001). &nbsp;</li>
<li>Highest absolute and placebo-adjusted EASI-75 of any biologic with 66.9% of participants treated with APG777 achieving EASI-75 compared to 24.6% on placebo (p &lt; 0.001) 
<ul>
<li>Pre-specified sensitivity analysis showed consistent results in both moderate and severe patients</li>
<li>Additionally, an exposure-response relationship was observed, with patients in the two highest quartiles of exposures achieving the highest EASI-75 response at Week 16, 83.3% for quartile three and 89.5% for quartile four
<ul>
<li>APEX Part B is testing a higher dose of APG777, which is projected to achieve average exposures in line with the highest quartile of exposures from Part A</li>
</ul>
</li>
</ul>
</li>
<li>Additional key secondaries were in line with standard of care, including vIGA 0/1 and EASI-90
<ul>
<li>vIGA 0/1 of 34.9% compared to placebo of 17.3% (p &lt; 0.05)</li>
<li>EASI-90 of 33.9% compared to placebo of 14.7% (p &lt; 0.05)</li>
<li>Patients in the highest quartile of exposures achieved the highest response, 63.2% vIGA 0/1 and 63.2% EASI-90 at Week 16</li>
</ul>
</li>
<li>Treatment of patients with APG777 led to rapid onset of itch relief and achieved statistically significant reduction by Week 1
<ul>
<li>50.7% reduction of Itch NRS from baseline compared to 23.2% (p &lt; 0.01)</li>
</ul>
</li>
<li>APG777 was well tolerated with a safety profile consistent with other agents in the class
<ul>
<li>Serious treatment-emergent adverse events (TEAEs) were rare for APG777-exposed patients (1.2% vs. 2.4% in placebo)</li>
<li>Discontinuation rate due to AEs was low for APG777-exposed patients (2.4%)</li>
<li>The most common TEAEs (occurring in ≥5% of patients in either treatment group) were non-infective conjunctivitis, upper respiratory tract infection, and nasopharyngitis, the latter two numerically lower in APG777 treated patients</li>
<li>There were 0 injection site reactions in the APG777 group</li>
</ul>
</li>
</ul>

Apogee Therapeutics' APG777 Shows Results in Atopic Dermatitis Trial

Eshallgo Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EHGO#NASDAQ">EHGO</a>), a leading provider of integrated office solutions in China, today announced that its wholly owned subsidiary, Shanghai ESHALLGO Enterprise Development (Group) Co., Ltd. ("ESHALLGO Group"), has entered into a nationwide strategic partnership agreement (the "Agreement") with Tianjin Photonetco Electronic Technology Co., Ltd. ("Photonetco"), one of China's top three office equipment manufacturers.
The Agreement appoints EHGO as Photonetco's exclusive national strategic partner, underscoring a critical advancement in EHGO's efforts to expand within China's growing office equipment market.
According to Cognitive Market Research, China's office printer market alone is valued at over USD 5 billion as of 2024, and is expected to grow at a compound annual growth rate (CAGR) of 6% through 2031. When including office consumables, services, and broader enterprise integration, the total addressable market exceeds USD 10 billion, driven by national policies promoting domestic technology adoption, data security, and procurement independence among Chinese enterprises.
Under the agreement, Photonetco will provide EHGO with more than 10 custom-developed printer models, ranging from entry-level to enterprise-grade categories, and grant EHGO nationwide distribution rights for both hardware and consumables. EHGO will also gain access to Photonetco's comprehensive national after-sales service and maintenance network. In addition, Photonetco will support EHGO through professional technical training, authorized service station support, formal authorization documentation for EHGO and its affiliates, and the provision of promotional and marketing materials as needed to strengthen market development and brand promotion efforts.

EHGO

Eshallgo Secures Exclusive Deal With Top Chinese Printer Maker, Taps Into $10B Office Tech Market

<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="585" src="https://contributor-assets.benzinga.com/wp-content/uploads/2025/07/06152238/AI-image-mdw02-created-in-MS-designer.jpeg-1024x585.jpeg" alt="" class="wp-image-15359" srcset="https://contributor-assets.benzinga.com/wp-content/uploads/2025/07/06152238/AI-image-mdw02-created-in-MS-designer.jpeg-1024x585.jpeg 1024w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/07/06152238/AI-image-mdw02-created-in-MS-designer.jpeg-300x172.jpeg 300w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/07/06152238/AI-image-mdw02-created-in-MS-designer.jpeg-768x439.jpeg 768w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/07/06152238/AI-image-mdw02-created-in-MS-designer.jpeg.jpeg 1200w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Credit: Image generated by AI
Some of the world's biggest cryptocurrency exchanges have started shifting their business on-chain, blending CEX stability with features only DEX users typically have access to.
A hybrid model is emerging that delivers blockchain benefits through a familiar TradFi UI: User-friendly in the front, blockchain-powered in the back. 
Will it be enough to de-risk DeFi for a mainstream finance audience?
<h1 class="wp-block-heading">Leaving the conventional brokerage model&nbsp;behind</h1>
Coinbase, Bybit, and Binance have all announced changes that weave Web3 protocols into their Web2 platforms.
Why would they want to risk venturing on-chain? Decentralized finance protocols can be notoriously difficult for end users, and there are long-standing concerns about security and regulatory oversight in this space.
The truth is that&nbsp;DeFi is growing too quickly to ignore, worth an estimated $20 billion last year and&nbsp;<a href="https://www.grandviewresearch.com/industry-analysis/decentralized-finance-market-report" target="_blank" rel="noreferrer noopener">forecast to reach $230 billion by 2030</a> — an annual CAGR of 50%.
<a href="https://www.grandviewresearch.com/industry-analysis/cryptocurrency-exchange-platform-market-report" rel="noreferrer noopener" target="_blank">Double-digit CAGR</a>&nbsp;is in the cards for CEXs too. But DeFi has almost double the momentum. They don't want to be left behind.
And that's a real risk. Centralized exchanges are basically modelled on conventional brokerages. They operate in ways that are familiar to everyday retail traders, but their technical infrastructure makes it hard to penetrate the on-chain space.
Recent announcements suggest the big CEXs are moving on from being matching platforms and evolving into deeply-integrated trading networks that fuse on-chain and off-chain benefits:
<h2 class="wp-block-heading">Coinbase Offers DEX Access Through Its&nbsp;CEX</h2>
On June 12, 2025, Coinbase announced it was integrating DEXs on its proprietary Base blockchain with its centralized exchange business, with plans in the pipeline to add DEXs from other blockchains.
For end users, the move opens up access to thousands of altcoins but without Ethereum's (ETH) gas fees, though Coinbase's trading fee structure still comes into play.
For big Base-built DEXs like&nbsp;<a href="https://x.com/AerodromeFi/status/1933246313682067730?ref_src=twsrc%5Etfw%7Ctwcamp%5Etweetembed%7Ctwterm%5E1933246313682067730%7Ctwgr%5E79e00aeb61d26ced5a04be1756a3ce082204c6b5%7Ctwcon%5Es1_c10&amp;ref_url=https%3A%2F%2Fwww.techopedia.com%2Fcentralized-crypto-exD181hanges-move-onchain" target="_blank" rel="noreferrer noopener">Aerodrome</a>, having a direct link to the mainstream Coinbase exchange has been a major boost. Its AERO token&nbsp;<a href="https://coinmarketcap.com/currencies/aerodrome-finance/" target="_blank" rel="noreferrer noopener">has spiked</a>&nbsp;since the announcement.
It's not the first time Coinbase has tried to leverage its Web2 footprint on-chain. The exchange's wrapped token for Bitcoin, cbBTC, was bootstrapped using Coinbase as the primary rail to attract liquidity and users.
With direct access to Base's lending markets, cbBTC holders can now borrow USDC using Bitcoin (BTC) as collateral, without leaving the Coinbase app.
<h2 class="wp-block-heading">Binance Aims for Wallet&nbsp;Share</h2>
In May, Binance launched its&nbsp;<a href="https://www.binance.com/en/square/post/24440234006465" rel="noreferrer noopener" target="_blank">Alpha campaign</a>, a series of trading contests that reward users with "Alpha Points" that can be used to buy selected digital assets, which users receive later in the form of airdrops. It's meant to encourage support for new projects and build grassroots engagement.
The approach has many steps, but Binance appears to have its eye on growing wallet use and participation in its on-chain ecosystem. To use Alpha points, they have to be traded through Binance's keyless Binance Wallet. This could be a way to funnel more users into Binance's proprietary DeFi services via the BNB blockchain.
It seems to be working. PancakeSwap is the tool&nbsp;<a href="https://www.binance.com/en/support/announcement/detail/c6499e95c15e408ca44ca5f6db975d4d" rel="noreferrer noopener" target="_blank">enabling Alpha token trades</a>, and its&nbsp;<a href="https://defillama.com/dexs/pancakeswap" rel="noreferrer noopener" target="_blank">volumes have surged</a>&nbsp;since Alpha's May launch.
<h2 class="wp-block-heading">Bybit Launches a Hybrid&nbsp;Exchange</h2>
On June 15, 2025, Bybit&nbsp;<a href="https://x.com/byreal_io/status/1934085435212308789?ref_src=twsrc%5Etfw%7Ctwcamp%5Etweetembed%7Ctwterm%5E1934085435212308789%7Ctwgr%5E79e00aeb61d26ced5a04be1756a3ce082204c6b5%7Ctwcon%5Es1_c10&amp;ref_url=https%3A%2F%2Fwww.techopedia.com%2Fcentralized-crypto-exD181hanges-move-onchain" rel="noreferrer noopener" target="_blank">announced</a>&nbsp;the launch of Byreal, a new Solana DEX that promises a hybrid exchange model that leverages centralized liquidity sources with decentralized execution. The combination should enable Byreal to route trades more profitably.
Positioned as an extension of Bybit rather than a new product, Byreal's design will see it route transactions via mechanisms called Concentrated Liquidity (CLMM) and Request for Quote (RFQ).
The idea is to unify liquidity sources and increase protection against MEV tactics by miners and validators. Execution is provided by market makers or liquidity providers, depending on the coin and conditions attached to the trade.
<h1 class="wp-block-heading">The take&nbsp;away</h1>
Three centralized exchanges, three on-chain strategies. Combined, they're loudly signalling that the on-chain economy has moved to a new phase of maturity. DeFi is demonstrating stability and security — two baseline requirements for regulated CEXs to integrate blockchain infrastructure into their technology stacks.
While the convergence gives big-name exchanges an on-chain presence, it also marks the start of a new model. We may be witnessing the birth of a crypto trading paradigm.

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Fintech news covering the emerging Financial Technology services sector

Fintech

Opinion

DEXs Are Quietly Turning Into CEXs. Here's What That Means For Traders

A former top executive at the Social Security Administration quietly floated an idea to park part of the program's $2.7 trillion trust fund in a short-term Treasury note that would automatically convert into an S&amp;P 500 index basket at maturity, but the proposal never really saw the light of day.
What Happened: Scott Coulter, who served as SSA chief information officer until spring, argued the hybrid debt-equity instrument could buy the program time by earning higher market returns than traditional special-issue bonds, according to an internal summary <a href="https://www.wsj.com/politics/policy/social-security-trust-insolvency-investments-f73c127c?gaa_at=eafs&amp;gaa_n=ASWzDAhXVvEEVlsG9pXe58j7ruDK_nXJIK0EwtgxHbSxU1FScgMuB4fhSqur-A8zIrQ%3D&amp;gaa_ts=686b7c7c&amp;gaa_sig=jerdUetjrn-XsqQ3RBbOOYT2KEmTFuBzqoSwVN0N0OMHcnbIIMtvTLN0qcW9VJDIWCudLqaYnUs7pxnxd5drqQ%3D%3D">seen</a> by The Wall Street Journal.
Coulter drafted the plan while acting as SSA's liaison to the Trump-backed Department of Government Efficiency. He proposed shifting only a slice of assets to limit risk, saying the note would give trustees an upside without violating the law's daily investment mandate. The trust fund currently invests exclusively in non-marketable Treasury securities.
See also: <a href="https://www.benzinga.com/personal-finance/management/25/07/46260419/social-security-trust-fund-remains-a-top-priority-for-the-trump-administration-assures-commissioner-bisignano-experts-arent-so-sure">Social Security Trust Fund &#8216;Remains A Top Priority For The Trump Administration,&#8217; Assures Commissioner Bisignano – Experts Aren&#8217;t So Sure</a>
Social Security Commissioner Frank Bisignano, who was confirmed for his role in May this year, shelved the idea. The former Fiserv chief told lawmakers that he&#8217;s more focused on fixing customer service first and integrating artificial intelligence tools. 
In a separate statement, Bisignano said <a href="https://www.benzinga.com/personal-finance/management/25/07/46260419/social-security-trust-fund-remains-a-top-priority-for-the-trump-administration-assures-commissioner-bisignano-experts-arent-so-sure">safeguarding the fund</a> "remains a top priority for the Trump administration."
Why It Matters: The non-partisan Committee for a Responsible Federal Budget warns that President Donald Trump's pending "One Big Beautiful Bill" would speed the depletion of the retirement reserve to 2032 by trimming taxes on benefits. Eliminating benefit taxes outright would <a href="https://www.benzinga.com/personal-finance/25/02/43831371/eliminating-social-security-income-taxes-would-cost-1-5-trillion-and-deplete-the-trust-fund-by-2032-who-wins-and-who-loses">drain $1.5 trillion more</a>, show estimates.
Treasury Secretary Scott Bessent has floated a broader <a href="https://www.youtube.com/watch?v=lSma9suyp24">fix</a> that involves pairing the program with a new sovereign wealth fund seeded by "baby bonds" for newborns. Any equity move, however, would need congressional approval and fresh borrowing to redeem existing bonds, an expensive step at today's rates, former trustee Charles Blahous noted while speaking to WSJ.
Read next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/25/07/46263553/social-security-administration-sends-unbelievable-email-on-trumps-big-beautiful-bill-report">Social Security Administration Sends &#8216;Unbelievable&#8217; Email On Trump&#8217;s &#8216;Big, Beautiful Bill&#8217;: Report</a></li>
</ul>
Image via Shutterstock

Financing

Former Social Security Executive Pitched S&P-Linked Treasury Plan To Extend Fund Solvency — Here's What Happened To It

Popular obesity treatments Wegovy and Zepbound are seeing price reductions, but patients still face significant barriers to sustained access despite strong market demand.
What Happened: The medications cost around $500 monthly for uninsured patients, while insured coverage remains inconsistent across plans. &#8220;Coverage is not the same as access,&#8221; said Beverly Tchang, a New York-based physician who advises both Novo Nordisk A/S (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NVO#NYSE">NVO</a>) and Eli Lilly and Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LLY#NYSE">LLY</a>), reported <a href="https://apnews.com/article/wegovy-zepbound-obesity-drugs-coverage-access-142e234c16df4443e8f66c27d01f44e2#">the</a> Associated Press.
GLP-1 receptor agonists continue driving substantial revenue for both drugmakers. Zepbound generated $2.3 billion in U.S. first-quarter sales, while Wegovy contributed nearly $1.9 billion with approximately 200,000 weekly prescriptions domestically.
Insurance coverage varies dramatically by provider and plan type. Novo Nordisk reports that 85% of covered U.S. patients pay $25 or less monthly. However, most state Medicaid programs and Medicare exclude obesity coverage, forcing patients to shoulder hundreds in out-of-pocket costs monthly, according to the report.
See Also: <a href="https://www.benzinga.com/markets/large-cap/25/07/46269182/ai-assistants-could-break-amazons-60-billion-retail-media-business-warns-vc-its-not-just-search-at-google-its-search-everywhere">AI Assistants Could Break Amazon&#8217;s $60 Billion Retail Media Business, Warns VC: &#8216;It&#8217;s Not Just Search At Google — It&#8217;s Search Everywhere&#8217;</a>
Why It Matters: The regulatory landscape remains complex regarding compounded versions. Despite FDA determinations that drug shortages ended, compounding pharmacies continue selling cheaper alternatives under personalization exceptions.
Hims &amp; Hers Health Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HIMS#NYSE">HIMS</a>) offers compounded semaglutide starting at $165 monthly, leading to legal challenges from Eli Lilly.
Recent pricing trends show that both companies reduced uninsured patient costs by several hundred dollars from initial launch prices. However, $500 monthly represents approximately 14% of the average U.S. per-capita income at $43,000 annually.
Long-term adherence data reveals persistence challenges that could impact market expansion. Real-world studies show only 8.1% of patients maintained GLP-1 obesity therapy after three years, though one-year persistence for Wegovy <a href="https://www.benzinga.com/news/health-care/25/06/46102213/us-adults-struggle-with-long-term-use-of-obesity-drugs-like-wegovy-data-shows">improved from 33.2% in 2021 to 62.7% in 2024</a>.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/health-care/25/07/46268630/alphabet-backed-drug-discovery-firm-nears-human-trials-of-ai-developed-remedies-says-president-the-next-big-milestone-is">Alphabet-Backed Drug Discovery Firm Nears Human Trials Of AI-Developed Remedies, Says President: &#8216;The Next Big Milestone Is…&#8217;</a></li>
</ul>
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Photo courtesy: Tobias Arhelger / Shutterstock.com

Health Care

Hims & Hers Health, Inc. Class A Common Stock

HIMS

Wegovy, Zepbound Prices Drop, But Most Patients Still Can't Afford Long-Term Use: 'Coverage Is Not The Same As Access,' Says Expert

Pony AI (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PONY#NASDAQ">PONY</a>) and Dubai&#8217;s Roads and Transport Authority (RTA) announced on Monday that they recently held a <a target="_blank" href="https://www.benzinga.com/pressreleases/25/07/g46268614/pony-ai-inc-and-dubai-rta-co-reveal-robotaxi-introduction" rel="noreferrer noopener">robotaxi unveiling ceremony</a> in Dubai, formalizing their partnership to advance L4 autonomous mobility solutions.
Under the agreement, the collaboration will deploy&nbsp;Pony AI&#8217;s autonomous driving technology through a multi-phase rollout.
Initial supervised robotaxi trials will begin in late 2025, paving the way for the launch of fully driverless service later in the decade.
Also Read: <a target="_blank" href="https://www.benzinga.com/trading-ideas/movers/25/06/46092236/pony-ai-rides-high-after-nasdaq-golden-dragon-china-index-inclusion" rel="noreferrer noopener">Pony.ai Rides High After Nasdaq Golden Dragon China Index Inclusion</a>
The strengthened alliance focuses on enhancing urban mobility efficiency, reducing traffic congestion, and establishing sustainable transportation models aligned with Dubai&#8217;s vision to transform the city&#8217;s urban travel landscape through autonomous mobility.
Pony AI has been actively expanding its global footprint, having already secured robotaxi operational permits in key markets including the U.S., China, South Korea, and Luxembourg.
<h2 class="wp-block-heading">Pony AI&#8217;s Recent Challenges And Strategic Moves</h2>
Pony.ai&#8217;s stock has seen a decline of over 15% year-to-date. The company has navigated challenges related to autonomous vehicle development, regulatory complexities, and geopolitical tensions between the U.S. and China, which have influenced investor sentiment regarding Chinese firms listed on U.S. exchanges.
Pony.ai has <a target="_blank" href="https://www.benzinga.com/25/05/45416148/pony-ai-shares-rise-after-report-of-confidential-hong-kong-ipo-to-fund-robotaxi-expansion" rel="noreferrer noopener">confidentially filed</a> for a Hong Kong IPO in a strategic move. This filing is intended to secure additional funding for expanding its autonomous mobility business, while seeking to minimize disruptions to its U.S.-listed stock. Pony.ai initially went public on Nasdaq on November 27, 2024, <a target="_blank" href="https://www.benzinga.com/node/42228125" rel="noreferrer noopener">raising approximately</a> $413 million in its U.S. IPO.
This potential Hong Kong listing aligns with the company&#8217;s increased focus on commercialization. Pony.ai aims to launch robotaxi services by mid-2025 and projects deploying 700 vehicles by year-end.
The company also reports a 70% reduction in development costs, suggesting improved efficiency in its latest autonomous systems. Executives anticipate reaching single-unit breakeven by the end of 2025, supported by these cost-cutting measures and scaling efforts.
Just days before the IPO filing, on May 13, 2025, one of Pony.ai&#8217;s fully autonomous vehicles caught fire in Beijing. No injuries were reported in the incident.
Further expanding its international reach, Pony.ai strategically partnered with Uber Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UBER#NYSE">UBER</a>) to launch robotaxi operations in the Middle East.
Earlier, CTO Lou Tiancheng indicated to The Wall Street Journal that Pony.ai was approaching breakeven as it streamlined its operations.
<h2 class="wp-block-heading">Industry Outlook</h2>
The broader autonomous vehicle industry continues to evolve rapidly. Bank of America analyst Martyn Briggs <a target="_blank" href="https://www.benzinga.com/markets/tech/25/07/46217099/autonomous-vehicles-best-stocks" rel="noreferrer noopener">recently noted</a> that autonomous vehicles have hit their &#8216;ChatGPT moment,&#8217; suggesting a pivotal point of accelerated development and adoption for the technology.
Price Action: PONY stock is trading higher by 0.70% to $12.95 premarket at last check Monday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/analyst-stock-ratings/reiteration/25/06/46100456/tesla-robotaxi-scaling-growth-will-be-slow-in-near-term-goldman-sachs" target="_blank" rel="noreferrer noopener">Tesla Robotaxi Scaling Growth Will Be Slow In Near Term: Goldman Sachs</a></li>
</ul>
Image via Shutterstock

Asia

PONY

UBER

Pony.ai To Deploy Robotaxis In Dubai, Trials Begin Late 2025

Press Releases

CalciMedica to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference

CalciMedica Announces Upcoming Plenary Presentation at the 30th International AKI & CRRT Conference

CalciMedica Presents AKI Data from a Post-Hoc Analysis of the Phase 2 CARDEA trial of Auxora™ in Severe COVID-19 Pneumonia at the 30th International AKI & CRRT Conference

CalciMedica Secures Credit Facility for Up to $32.5 Million

Earnings

CalciMedica Reports 2024 Financial Results and Provides Clinical & Corporate Updates

CalciMedica to Participate in the Jones Healthcare and Technology Innovation Conference

CalciMedica Announces Presentations at Upcoming Medical Meetings

CalciMedica Reports First Quarter 2025 Financial Results and Provides Clinical & Corporate Updates

CalciMedica Announces Upcoming Symposium at the 43rd Vicenza Course AKI-CRRT-EBPT and Critical Care Nephrology Meeting

CalciMedica Announces Publication in the American Journal of Nephrology Discussing Design and Rationale of Phase 2 KOURAGE Trial of Auxora™ in AKI with Respiratory Failure

Comments

CalciMedica

CalciMedica (CALC) Opzioni

No option chain data available. Please try again later

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO